A preliminary analysis of luspatercept use and expenditure in Italy in the first semester of 2022. Letter

Ann Ist Super Sanita. 2023 Apr-Jun;59(2):99-100. doi: 10.4415/ANN_23_02_01.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Activin Receptors, Type II
  • Health Expenditures*
  • Humans
  • Immunoglobulin Fc Fragments*
  • Italy

Substances

  • luspatercept
  • Immunoglobulin Fc Fragments
  • Activin Receptors, Type II